Synthesis and Release of Thyroid Hormones

Virulence Factors

Virulence factors are molecules expressed and secreted by pathogens (bacteria, viruses, fungi and protozoa) that enable them to achieve the following: * colonization of a niche in the host (this i...

Drug Delivery - news, views, blogs

Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals.  Drug delivery technologies are patent protected formulat...

Pain

Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in term...

Biosimilars - news, reports, views and blogs

Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusi...

FDA approves Raptor's Procysbi delayed release capsules

The US Food and Drug Administration (FDA) has approved Raptor's Procysbi (cysteamine bitartrate) delayed release capsules for the treatment of nephropathic cystinosis in adults and children six years...

Breckenridge Announces Approval for Lansoprazole Delayed-Release Rx Capsules

BOCA RATON, Fla., Dec. 18, 2012 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Prescription Lansoprazole Delayed-Release Capsules.  The U.S. Food a...

FDA accepts Raptor NDA for Cysteamine Bitartrate delayed-release capsules

Raptor Pharmaceutical has announced FDA acceptance of new drug application (NDA) for Cysteamine Bitartrate delayed-release capsules (RP103) for the potential treatment of nephropathic cystinosis.

Wockhardt launches generic version of anti─ulcer drug Prevacid

Wockhardt has received final approval from the US FDA for marketing 15 mg and 30 mg delayed release capsules of lansoprazole, which is used in treatment of peptic ulcers.

Pancrelipase DR caps approved for EPI

FDA has approved Pancrelipase delayed-release capsules to treat exocrine pancreatic insufficiency resulting from cystic fibrosis or other conditions.

Elite Pharmaceuticals, Inc. Announces Approval of Phentermine Capsules and Delayed Launch

NORTHVALE, N.J., Oct. 15, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced that Elite received approval as of September 28th from the U.S....

FDA approves Eisai's Aciphex Sprinkle for pediatric GERD

The FDA has approved the use of Eisai's Aciphex Sprinkle delayed-release capsules, or rabeprazole sodium, for up to 12 weeks  -More- 

US FDA grants standard review for Raptor cystinosis treatment

Investors cheered the US FDA's acceptance of Raptor Pharmaceutical's new drug application (NDA) for RP103 (cysteamine bitartrate delayed-release capsules) as a treatment for nephropathic cystinosis,...

Light-addressable capsules as caged compound matrix for controlled triggering of cytosolic reactions.

Release me: Polyelectrolyte capsules with different cargo in their cavities and plasmonic and magnetic nanoparticles in their walls were synthesized. Enzymatic reactions were triggered inside cells by...

"Smart" capsules for drug release: charge-shifting click capsules with dual-responsive cargo release mechanisms (adv. Mater. 36/2011).

Remote control over guidance and release properties of composite polyelectrolyte based capsules.

Polyelectrolyte multilayer capsules represent a unique tool to fabricate micron- and submicron-sized delivery systems with the properties of external guidance by means of remote physical influence. Em...

Polymer Microcapsules with Programmable Active Release.

We present a new type of microcapsule programmed with a tunable active release mechanism. The capsules are triggered by a plasticizing stimulus which induces a phase change transition of the polymeric...

Encapsulation of R. planticola Rs-2 from alginate-starch-bentonite and its controlled release and swelling behavior under simulated soil conditions.

The plant growth-promoting bacteria (PGPR) Raoultella planticola Rs-2 was encapsulated with the various blends of alginate, starch, and bentonite for development of controlled-release formulations. Th...